References
- Dever JB, Sheikh MY. Review article: spontaneous bacterial peritonitis–bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther. 2015;41:1116–1131.
- Fiore M. Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated? Eur J Gastroenterol Hepatol. 2016;28:731.
- Friedrich K, Nüssle S, Rehlen T, et al. Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis. J Gastroenterol Hepatol. 2016;31(6):1191–1195.
- Piano S, Fasolato S, Salinas F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: results of a randomized, controlled clinical trial. Hepatology. 2016;63(4):1299–1309.
- Fernandez J, Prado V, Trebicka J, et al. Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol. 2019;70:398–411.
- Novovic S, Semb S, Olsen H, et al. First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage. Scand J Gastroenterol. 2012;47(2):212–216.
- Fiore M, Di Franco S, Alfieri A, et al. Spontaneous bacterial peritonitis caused by Gram-negative bacteria: an update of epidemiology and antimicrobial treatments. Expert Rev Gastroenterol Hepatol. 2019;13(7):683–692.
- Klein EY, Tseng KK, Pant S, et al. Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index. BMJ Glob Health. 2019;4(2):e001315.
- Bernardi M. Spontaneous bacterial peritonitis: from pathophysiology to prevention. Intern Emerg Med. 2010;5(S1):37–44.
- Aagaard NK, B F, Grønbaek H, et al. Behandling af ascites, spontan bakteriel peritonitis, hepatorenalt syndrom og hyponatriaemi ved levercirrose NBV. 2017. Available from: https://www.dsgh.dk/images/Guidelines/pdf/Ascites.pdf
- Felisart J, Rimola A, Arroyo V, et al. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology. 1985;5(3):457–462.
- Acevedo J, Fernandez J. New determinants of prognosis in bacterial infections in cirrhosis. WJG. 2014;20(23):7252–7259.
- Lutz P, Nischalke HD, Krämer B, et al. Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis. Eur J Clin Invest. 2017;47(1):44–52.
- Umgelter A, Reindl W, Miedaner M, et al. Failure of current antibiotic first-line regimens and mortality in hospitalized patients with spontaneous bacterial peritonitis. Infection. 2009;37(1):2–8.
- Fiore M, Gentile I, Maraolo AE, et al. Are third-generation cephalosporins still the empirical antibiotic treatment of community-acquired spontaneous bacterial peritonitis? A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2018;30:329–336.
- Fiore M, Maraolo AE, Gentile I, et al. Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: a systematic review. WJG. 2017;23(25):4654–4660.
- Wieser A, Li H, Zhang J, et al. Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis. Dig Liver Dis. 2019;51(9):1300–1307.